Wells Fargo’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Wells Fargo’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,783	Closed	-$1.3M	–	7292
2023 Q2	$1.3M	Buy	12,783 +5,867	+85%	+$598K	﹤0.01%	3084
2023 Q1	$629K	Buy	6,916 +6,054	+702%	+$550K	﹤0.01%	3462
2022 Q4	$32.7K	Sell	862 -133	-13%	-$5.05K	﹤0.01%	4740
2022 Q3	$25K	Sell	995 -1,131	-53%	-$28.4K	﹤0.01%	4975
2022 Q2	$65K	Sell	2,126 -7,956	-79%	-$243K	﹤0.01%	4635
2022 Q1	$330K	Sell	10,082 -17,763	-64%	-$581K	﹤0.01%	4412
2021 Q4	$734K	Buy	27,845 +8,826	+46%	+$233K	﹤0.01%	4093
2021 Q3	$1.91M	Buy	19,019 +4,081	+27%	+$410K	﹤0.01%	3519
2021 Q2	$2.11M	Buy	14,938 +4,796	+47%	+$679K	﹤0.01%	3470
2021 Q1	$1.01M	Sell	10,142 -357	-3%	-$35.6K	﹤0.01%	3981
2020 Q4	$1.3M	Sell	10,499 -2,451	-19%	-$303K	﹤0.01%	3767
2020 Q3	$1.26M	Buy	12,950 +4,998	+63%	+$486K	﹤0.01%	3608
2020 Q2	$1.24M	Sell	7,952 -7,512	-49%	-$1.17M	﹤0.01%	3569
2020 Q1	$2.23M	Sell	15,464 -2,456	-14%	-$354K	﹤0.01%	2842
2019 Q4	$3.66M	Sell	17,920 -67,873	-79%	-$13.9M	﹤0.01%	2821
2019 Q3	$6.89M	Buy	85,793 +49,325	+135%	+$3.96M	﹤0.01%	2248
2019 Q2	$3.44M	Sell	36,468 -6,939	-16%	-$655K	﹤0.01%	2864
2019 Q1	$3.71M	Sell	43,407 -1,899	-4%	-$162K	﹤0.01%	2812
2018 Q4	$2.54M	Buy	45,306 +22,041	+95%	+$1.24M	﹤0.01%	3031
2018 Q3	$1.9M	Buy	23,265 +666	+3%	+$54.5K	﹤0.01%	3411
2018 Q2	$790K	Buy	22,599 +1,908	+9%	+$66.7K	﹤0.01%	4085
2018 Q1	$425K	Sell	20,691 -25,776	-55%	-$529K	﹤0.01%	4399
2017 Q4	$1.32M	Buy	46,467 +11,095	+31%	+$314K	﹤0.01%	3665
2017 Q3	$1.1M	Buy	35,372 +29,781	+533%	+$925K	﹤0.01%	3717
2017 Q2	$176K	Buy	5,591 +1,521	+37%	+$47.9K	﹤0.01%	4687
2017 Q1	$93K	Hold	4,070	–	–	﹤0.01%	4986
2016 Q4	$88K	Buy	4,070 +1,913	+89%	+$41.4K	﹤0.01%	4981
2016 Q3	$57K	Buy	+2,157	New	+$57K	﹤0.01%	4997